We found that TLR4 was upregulated in ccRCC samples at both gene expression and protein levels, and TLR4 knockdown inhibited the proliferative, invasive, and migratory abilities of ccRCC cells, which shows potential for providing a new strategy for ccRCC patients. Here, TLR4 is linked to nonpapillary renal cell carcinoma.